<?xml version="1.0" encoding="UTF-8"?>
<ref id="B72">
 <label>72.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Pimentel</surname>
    <given-names>T.A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Yan</surname>
    <given-names>Z.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Jeffers</surname>
    <given-names>S.A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Holmes</surname>
    <given-names>K.V.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hodges</surname>
    <given-names>R.S.</given-names>
   </name>, and 
   <name name-style="western">
    <surname>Burkhard</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine</article-title>. 
  <source>Chem Biol Drug Design</source>
  <volume>73</volume>
  <bold>,</bold>
  <fpage>53</fpage>, 
  <year>2009</year>
 </mixed-citation>
</ref>
